Bisacodyl Oral for Lowering Dysfunction (of Tenckhoff Catheter)

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorChinese University of Hong Kong

About this trial

Doctors need to insert catheter for patients who are going to have peritoneal dialysis. These peritoneal catheters can be obstructed or blocked afterward. The chance of not having smooth flow can be up to 12 and 31%. So far, constipation is one of the proposed reasons. Therefore, the study is aimed to investigate whether the preventive use of laxative before the surgery can help better improve the function of the catheter and hence better flow.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

aged 18 or older and need of peritoneal dialysis

willingness to give written consent and comply with the study protocol

Disqualifiers

known contraindication to peritoneal dialysis

ongoing diarrhoea or active inflammatory bowel disease

participation in another interventional study within last 30 days of randomization

history of a psychological illness or condition that would interfere with the patient's ability to understand the requirement of the study and/or comply with the dialysis procedures

Trial design

Design model

Parallel

Treatments tested in this trial

  • Bisacodyl 5 mg

    Drug

    In the intervention arm, the protocol of prophylactic laxative is administration of oral enteric coated bisacodyl 5 mg at bedtime for two consecutive days prior to Tenckhoff catheter insertion. In the control arm, patients will receive usual care, and are allowed to continue their usual laxative, without extra prescription.

Treatment groups

398 Participants
are divided into 2 treatment groups
Group A: Bowel preparationActive comparator 1 intervention
Group B: Usual careNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Catheter dysfunction

Primary outcome is the incidence of catheter dysfunction that requires simple and invasive manipulation by fluoroscopic or surgical procedure. Catheter dysfunction refers to drainage failure, as defined by the inability to drain peritoneal dialysate effluent reliably within 45 minutes. Simple intervention includes use of irrigation of catheter with saline, fibrinolytic agent such as urokinase and extra laxative use. Invasive manipulation of catheter includes repositioning or reinsertion, either by fluoroscopic method, open surgical or laparoscopic method.

Time frame
within 4 weeks of catheter insertion

Secondary outcomes

1

Catheter dysfunction and survival

The time to catheter dysfunction requiring invasive intervention

Time frame
3 months after catheter insertion for early peritonitis
2

The incidence of early peritonitis (within 3 months of catheter insertion)

Peritonitis

Time frame
3 months after catheter insertion
3

The peritoneal catheter survival

catheter survival

Time frame
3 months after catheter insertion

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: